VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ASPIASP Isotopes Inc. Common Stock
$7.18$597M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ASPI logoASP Isotopes Inc. Common Stock(ASPI)Earnings, Financials & Key Ratios

ASPI•NASDAQ
Price updated Jun 19, 2026
SectorBasic MaterialsIndustryChemicalsSub-IndustryNuclear materials and mineral development
AboutASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.Show more
  • Revenue$24M+475.5%
  • EBITDA-$55M-113.6%
  • Net Income-$175M-441.5%
  • EPS (Diluted)-2.11-234.9%
  • Gross Margin14.28%-63.0%
  • EBITDA Margin-231.79%+62.9%
  • Operating Margin-239.8%+62.3%
  • Net Margin-734.17%+5.9%
  • ROE-111.5%-20.7%

ASPI Key Insights

ASP Isotopes Inc. Common Stock (ASPI) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 80 (top 20%)

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Shares diluted 49.1% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ASPI posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ASPI Price & Volume

ASP Isotopes Inc. Common Stock (ASPI) stock price & volume — 10-year historical chart

Loading chart...

ASPI Growth Metrics

ASP Isotopes Inc. Common Stock (ASPI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM511.23%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-412.9%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-224.5%

Return on Capital

10 Years-51.1%
5 Years-51.1%
3 Years-52.93%
Last Year-20.16%

ASPI Recent Earnings

ASP Isotopes Inc. Common Stock (ASPI) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 1/12 qtrs (13%)●Beat Revenue 2/12 qtrs (25%)
Q2 2026Latest
May 20, 2026
Metric
Actual
Est
EPS
$0.22+19.5%
$0.27
Rev
$4M-5.6%
$4M
Q2 2026
Apr 10, 2026
Metric
Actual
Est
EPS
$0.84-514.6%
$0.14
Rev
$17M+721.3%
$2M
Q4 2025
Nov 19, 2025
Metric
Actual
Est
EPS
$0.15+0.0%
$0.15
Rev
$5M+140.8%
$2M
Q3 2025
Aug 14, 2025
Metric
Actual
Est
EPS
$1.03+0.0%
$1.03
Rev
$1M-25.1%
$2M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 20, 2026
$0.22vs $0.27+19.5%
$4Mvs $4M-5.6%
Q2 2026Apr 10, 2026
$0.84vs $0.14-514.6%
$17Mvs $2M+721.3%
Q4 2025Nov 19, 2025
$0.15vs $0.15+0.0%
$5Mvs $2M+140.8%
Q3 2025Aug 14, 2025
$1.03vs $1.03+0.0%
$1Mvs $2M-25.1%
Based on last 12 quarters of dataView full earnings history →

ASPI Peer Comparison

ASP Isotopes Inc. Common Stock (ASPI) competitors in Nuclear materials and mineral development — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NTIC logoNTICNorthern Technologies International CorporationDirect Competitor76.22M8.044466.67-0.97%-0.35%-0.4%0.17
LEU logoLEUCentrus Energy Corp.Product Competitor3.63B191.3949.071.52%13.4%10.71%1.59
UEC logoUECUranium Energy Corp.Product Competitor5.94B12.01-60.05297.38%-5.16%-8.13%0.00
NNE logoNNENano Nuclear Energy IncProduct Competitor1.17B28.21-26.61-7.62%0.01
UUUU logoUUUUEnergy Fuels Inc.Product Competitor4.14B16.58-44.81-15.61%-82.7%-10.16%0.99
DNN logoDNNDenison Mines Corp.Product Competitor3.03B3.35-18.9022.25%-59.09%-65.41%1.67
CCJ logoCCJCameco CorporationSupply Chain46.37B106.49111.2610.95%16.93%8.76%0.15
SMR logoSMRNuScale Power CorporationSupply Chain1.57B11.72-5.40-15.02%-20.67%-48.88%

Compare ASPI vs Peers

ASP Isotopes Inc. Common Stock (ASPI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NTIC

Most directly comparable listed peer for ASPI.

Scale Benchmark

vs GEV

Larger-name benchmark to compare ASPI against a more recognizable public peer.

Peer Set

Compare Top 5

vs NTIC, LEU, UEC, NNE

ASPI Income Statement

ASP Isotopes Inc. Common Stock (ASPI) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
00433.03K4.14M23.85M26.93M
Revenue Growth %
---856.99%475.51%511.23%
Cost of Goods Sold
19.38K0294.06K2.54M20.44M22.18M
COGS % of Revenue
--67.91%61.41%85.72%-
Gross Profit
-19.38K▲ 0%
0▲ 100.0%
138.97K▲ 0%
1.6M▲ 1050.6%
3.4M▲ 112.9%
4.74M▲ 0%
Gross Margin %
--32.09%38.59%14.28%17.62%
Gross Profit Growth %
-100%-1050.61%112.95%-
Operating Expenses
2.59M5.1M16.18M27.95M60.6M78.87M
OpEx % of Revenue
--3736.72%674.54%254.08%-
Selling, General & Admin
2.55M3.83M15.42M24.81M48.24M62.78M
SG&A % of Revenue
--3560.15%598.79%202.26%-
Research & Development
41.61K1.27M764.58K3.14M12.36M16.09M
R&D % of Revenue
--176.57%75.75%51.82%-
Other Operating Expenses
000000
Operating Income
-2.61M▲ 0%
-5.1M▼ 95.5%
-16.04M▼ 214.6%
-26.35M▼ 64.3%
-57.19M▼ 117.0%
-74.13M▲ 0%
Operating Margin %
---3704.63%-635.96%-239.8%-275.28%
Operating Income Growth %
--95.51%-214.61%-64.28%-117.01%-
EBITDA
-2.59M-4.95M-16M-25.88M-55.28M-69.31M
EBITDA Margin %
---3695.98%-624.59%-231.79%-257.38%
EBITDA Growth %
--91.03%-223.64%-61.72%-113.57%-147.75%
D&A (Non-Cash Add-back)
19.38K037.43K471K1.91M4.82M
EBIT
-2.61M-4.95M-16.18M-32.05M-158.99M-175.43M
Net Interest Income
1153.38K-109.47K979.82K6.21M7.11M
Interest Income
1153.38K9.07K1.24M6.79M9.32M
Interest Expense
00118.55K258.87K575K2.22M
Other Income/Expense
113153.91K-258.26K-5.96M-102.37M-103.64M
Pretax Income
-2.61M▲ 0%
-4.95M▼ 89.6%
-16.3M▼ 229.6%
-32.31M▼ 98.2%
-159.56M▼ 393.8%
-177.77M▲ 0%
Pretax Margin %
---3764.27%-779.73%-669.05%-660.17%
Income Tax
00-6.13K111.45K282K321.72K
Effective Tax Rate %
0%0%0.04%-0.34%-0.18%-0.18%
Net Income
-2.61M▲ 0%
-4.95M▼ 89.6%
-16.29M▼ 229.3%
-32.33M▼ 98.5%
-175.09M▼ 441.5%
-173.52M▲ 0%
Net Margin %
---3761.03%-780.26%-734.17%-644.41%
Net Income Growth %
--89.62%-229.34%-98.54%-441.51%-412.9%
Net Income (Continuing)
-2.61M-4.95M-16.29M-32.42M-159.84M-178.09M
Discontinued Operations
000001000K
Minority Interest
002.53M3.27M58.75M10.02M
EPS (Diluted)
-0.08▲ 0%
-0.13▼ 71.3%
-0.49▼ 276.9%
-0.63▼ 28.6%
-2.11▼ 234.9%
-1.43▲ 0%
EPS Growth %
--71.28%-276.92%-28.57%-234.92%-224.5%
EPS (Basic)
-0.08-0.13-0.49-0.63-2.11-
Diluted Shares Outstanding
34.36M35.91M33.07M55.67M83.01M121M
Basic Shares Outstanding
34.36M35.91M33.07M55.67M83.01M121M
Dividend Payout Ratio
------

ASPI Balance Sheet

ASP Isotopes Inc. Common Stock (ASPI) balance sheet — assets, liabilities & shareholders' equity

MetricDec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
3.22M3.3M10.51M65.74M398.14M308.74M
Cash & Short-Term Investments
2.95M2.39M7.91M61.89M333.31M290.52M
Cash Only
2.95M2.39M7.91M61.89M285.56M207.35M
Short-Term Investments
000047.74M83.17M
Accounts Receivable
00938.05K734.48K51.71M4.59M
Days Sales Outstanding
--790.6964.69791.4465.83
Inventory
00065.66K8.49M1.37M
Days Inventory Outstanding
---9.42151.6550.51
Other Current Assets
0913K1.66M3.05M2.64M12.27M
Total Non-Current Assets
3.92M9.19M19.68M28.6M114.74M278.93M
Property, Plant & Equipment
3.92M9.05M11.97M23.48M34.96M94.66M
Fixed Asset Turnover
--0.04x0.18x0.68x0.57x
Goodwill
003.27M3.17M8.57M6.39M
Intangible Assets
00001.48M675K
Long-Term Investments
000049M81.99M
Other Non-Current Assets
0139.64K4.44M-3.81M5.87M152.27M
Total Assets
7.14M▲ 0%
12.5M▲ 75.0%
30.19M▲ 141.6%
94.35M▲ 212.5%
512.88M▲ 443.6%
587.67M▲ 0%
Asset Turnover
--0.01x0.04x0.05x0.07x
Asset Growth %
-74.95%141.57%212.54%443.61%1307.01%
Total Current Liabilities
303.35K1.94M5.67M7.06M32.7M70.37M
Accounts Payable
59.68K1.35M1.11M1.02M5.75M6.87M
Days Payables Outstanding
1.12K-1.38K146.49102.7576.71
Short-Term Debt
84.97K33.85K470.4K939.11K13.64M54.22M
Deferred Revenue (Current)
00882K882K882K3.53M
Other Current Liabilities
158.7K140.46K1.97M1.26M8.84M8.4M
Current Ratio
10.62x1.71x1.85x9.31x12.18x4.39x
Quick Ratio
10.62x1.71x1.85x9.31x11.92x4.37x
Cash Conversion Cycle
----72.38840.3439.64
Total Non-Current Liabilities
841.62K742.44K5.68M41.87M217.29M218.28M
Long-Term Debt
00034.87M200.79M204.95M
Capital Lease Obligations
841.62K742.44K1.27M1.25M1.53M6.47M
Deferred Tax Liabilities
00110.58K014.96M21.25M
Other Non-Current Liabilities
004.3M5.74M03.87M
Total Liabilities
1.14M2.68M11.36M43.18M249.98M288.65M
Total Debt
926.6K822.2K2.14M37.75M215.96M261.84M
Net Debt
-2.03M-1.57M-5.77M-24.14M-69.6M54.49M
Debt / Equity
0.15x0.08x0.11x0.74x0.82x0.88x
Debt / EBITDA
------3.78x
Net Debt / EBITDA
------0.79x
Interest Coverage
---136.50x-123.82x-276.50x-79.13x
Total Equity
6M▲ 0%
9.82M▲ 63.7%
18.83M▲ 91.8%
51.17M▲ 171.7%
262.9M▲ 413.8%
299.02M▲ 0%
Equity Growth %
-63.69%91.81%171.72%413.81%1194.8%
Book Value per Share
0.170.270.570.923.172.47
Total Shareholders' Equity
6M9.82M16.3M47.9M204.15M289M
Common Stock
206.53K359.07K489.23K720.68K1.12M1.26M
Retained Earnings
-2.61M-7.55M-23.84M-56.17M-231.26M-238.52M
Treasury Stock
000000
Accumulated OCI
18.72K255.03K-920.98K-2.16M2.54M-2.66M
Minority Interest
002.53M3.27M58.75M10.02M

ASPI Cash Flow Statement

ASP Isotopes Inc. Common Stock (ASPI) cash flow — operating, investing & free cash flow history

MetricDec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-577.69K-2.94M-5.41M-16.7M-37.78M-52.37M
Operating CF Margin %
---1249.9%-402.88%-158.41%-
Operating CF Growth %
--408.9%-84.1%-208.47%-126.29%-972.22%
Net Income
-2.61M-4.95M-16.29M-32.42M-175.09M-173.52M
Depreciation & Amortization
19.38K72.57K37.43K471.42B1.91M4.82M
Stock-Based Compensation
02M8.74M8.56M013.33M
Deferred Taxes
0-72.57K16.66K-143.28K-45K-40.16K
Other Non-Cash Items
2.23M-27.96K924.12K-471.41B139.07M115.13M
Working Capital Changes
-238.21K33.89K1.16M-2.62M-3.63M-11.73M
Change in Receivables
00237.95K-505.95K-454K-1.01M
Change in Inventory
000-67.64K-315K-523K
Change in Payables
59.68K570.6K-224.6K-877.47K782K-452.22K
Cash from Investing
-2.99M-4.47M-2.45M-11.37M-90M-184.82M
Capital Expenditures
-2.99M-4.47M-2.33M-11.37M-9.65M-13.43M
CapEx % of Revenue
--538.38%274.43%40.48%49.88%
Acquisitions
00-121.85K025.37M30.29M
Investments
------
Other Investing
0000-29.97M-80.51M
Cash from Financing
6.5M6.64M13.39M82.53M350.8M394.19M
Debt Issued (Net)
46.9K-13.05K-180.53K25.72M44.11M42.51M
Equity Issued (Net)
6.45M8.12M14.13M53.09M307.09M306.82M
Dividends Paid
000-2.78T00
Share Repurchases
000000
Other Financing
0-1.47M-563.47K2.78T-402K44.86M
Net Change in Cash
2.93M▲ 0%
-564.58K▼ 119.2%
5.52M▲ 1077.5%
53.98M▲ 878.1%
223.67M▲ 314.3%
154.15M▲ 0%
Free Cash Flow
-3.57M▲ 0%
-7.41M▼ 107.9%
-7.74M▼ 4.5%
-28.07M▼ 262.5%
-47.43M▼ 69.0%
-65.8M▲ 0%
FCF Margin %
---1788.28%-677.31%-198.89%-244.37%
FCF Growth %
--107.89%-4.46%-262.46%-69%-123.96%
FCF per Share
-0.10-0.21-0.23-0.50-0.57-0.54
FCF Conversion (FCF/Net Income)
0.22x0.59x0.33x0.52x0.22x0.38x
Interest Paid
000000
Taxes Paid
000000

ASPI Key Ratios

ASP Isotopes Inc. Common Stock (ASPI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2022202320242025TTM
Return on Equity (ROE)
-62.54%-113.7%-92.39%-111.5%-101.06%
Return on Invested Capital (ROIC)
-62.59%-112.89%-98.61%-38.94%-31.52%
Gross Margin
-32.09%38.59%14.28%17.62%
Net Margin
--3761.03%-780.26%-734.17%-644.41%
Debt / Equity
0.08x0.11x0.74x0.82x0.88x
Interest Coverage
--136.50x-123.82x-276.50x-79.13x
FCF Conversion
0.59x0.33x0.52x0.22x0.38x
Revenue Growth
--856.99%475.51%511.23%
Related:ASPI Dividend History·ASPI Revenue History·ASPI Price History·ASPI P/E History·ASPI Financial Ratios·ASPI Institutional Holders

ASPI SEC Filings & Documents

ASP Isotopes Inc. Common Stock (ASPI) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 26, 2026·SEC

Material company update

May 20, 2026·SEC

Material company update

May 11, 2026·SEC

10-K Annual Reports

1
FY 2026

Apr 10, 2026·SEC

10-Q Quarterly Reports

3
FY 2026

May 20, 2026·SEC

FY 2025

Nov 19, 2025·SEC

FY 2025

Aug 14, 2025·SEC

ASPI Frequently Asked Questions

ASP Isotopes Inc. Common Stock (ASPI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

ASP Isotopes Inc. Common Stock (ASPI) reported $26.9M in revenue for fiscal year 2025.

ASP Isotopes Inc. Common Stock (ASPI) grew revenue by 475.5% over the past year. This is strong growth.

ASP Isotopes Inc. Common Stock (ASPI) reported a net loss of $173.5M for fiscal year 2025.

Dividend & Returns

ASP Isotopes Inc. Common Stock (ASPI) has a return on equity (ROE) of -111.5%. Negative ROE indicates the company is unprofitable.

ASP Isotopes Inc. Common Stock (ASPI) had negative free cash flow of $65.8M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in ASPI back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →

How much would $100/month in ASPI be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →